Navigation Links
ARRA Funding Encourages EMR Purchases at the Expense of PACS, RIS and CVIS Systems
Date:12/4/2013

TORONTO, Dec. 4, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States market for picture archiving and communication systems (PACS), radiology information systems (RIS) and cardiovascular information systems (CVIS) will be hindered by the shift in purchasing priorities in the US in favor of electronic medical records (EMRs). American Recovery and Reinvestment Act (ARRA) incentive funding for EMRs caused many facilities to prioritize implementing these systems over PACS, RIS or CVIS. Unit sales for these systems will pick up somewhat in 2014 and 2015, after most facilities have implemented EMRs and can direct funding to replace their aging PACS, RIS and CVIS.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

"Traditionally, diagnostic imaging system vendors such as GE Healthcare and Philips Healthcare have led this market," said MRG Senior Analyst Mickel Phung. "However, we've seen a shift in recent years in favor of Healthcare IT vendors. In large community and academic/research hospitals, enterprise-wide IT selection is now primarily performed by CIOs and the board of directors, who base their purchasing decisions more heavily on the integration capabilities of PACS, RIS and CVIS rather than on their functionality and performance."

Wide adoption of EMR systems in these healthcare settings has further fueled this trend, as hospitals opt to obtain imaging informatics products from their EMR vendor. As a result, McKesson, a well-known EMR and health information system (HIS) vendor, led the overall market in 2013. Similarly, well-known EMR vendors Epic and Cerner dominated the US RIS market in 2013.

Overall, the market will grow at a compound annual growth rate of only approximately two percent through 2022. Despite growing data imaging volumes and an increasing need for advanced management and reporting capabilities, this market will be restrained by budgetary constraints in the US healthcare system.

Millennium Research Group's US Markets PACS, RIS, and CVIS 2014 report includes unit, installed base, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for radiology PACS, RIS and CVIS/CPACS in the United States.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tyber Medical Closes Private Placement Funding Round
2. Indiana Biosciences Research Institute Hits $50 Million Start-Up Funding Goal
3. NanoBio Awarded Up To $10 Million In NIH Funding To Develop A Pandemic Influenza Vaccine
4. Epiditi - "COOL THE JEWELS!" The Only Form-Fitting Scrotal Ice Pack on the Planet - Now A Medical Crowdfunding Project
5. Yaz Settlement Funding News: 10K Cases Still Not Settled
6. Predilytics Secures Additional Funding and Expands Board of Directors
7. APPLIED INTEGRIN SCIENCES, INC. LAUNCHES CROWDFUNDING CAMPAIGN TO RAISE FUNDS FOR ITS CANCER DRUG DEVELOPMENT PROGRAM
8. NextDocs Receives $13.5 Million in Funding to Fuel Expansion
9. Perle BioScience Selects BlazeFund As Its Crowd Funding Platform
10. WaferGen Bio-systems Announces New Funding from Private Placement
11. Acutus Medical Closes Series B Funding at $28 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):